Pfizer and Sangamo’s haemophilia A gene therapy shows promise at Phase 1/2
July 8, 2019Research and Development, Sales and Marketing Pfizer, Sangamo, haemophilia, pharma
Pfizer and Sangamo Therapeutics have shared new Phase 1/2 data for their investigational SB-525 gene therapy in the treatment of …
New urine test can diagnose and offer prognosis for prostate cancer
July 8, 2019Sales and Marketing Cancer, oncology, pharma, prostate cancer, urine test
A new urine test can diagnose cases of aggressive prostate cancer more quickly than invasive biopsies. The test can also …
Trump says executive order will ensure US will pay lowest prices in the world for drugs
July 8, 2019Sales and Marketing Trump, US, executive order, pharma, politics, pricing
President Donald Trump has said that the White House is working on a ‘favoured nation clause’ to ensure the United …
GSK opens new manufacturing plants in Singapore
July 5, 2019Manufacturing and Production Asia, HIV, Singapore, anaemia, facilities, manufacturing, pharma
British multinational GlaxoSmithKline has opened two new manufacturing plants in Singapore. The UK firm has also expanded facilities at its …
ABPI Chief Executive Mike Thompson to retire by the end of 2019
July 5, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Mike Thompson, pharma
The Association of the British Pharmaceutical Industry (ABPI) has announced that its Chief Executive Mike Thompson is to retire from …
Top Ten most popular articles on Pharmafile.com this week!
July 5, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brenntag, Elizabeth Warren, HIV, Novartis, PrEP, cannabis, crispr, pharma
The top story of this week covered Novartis’ announcement that they did not send chemicals that could be used to …
FDA sharpen focus on pharmaceutical companies under Trump
July 5, 2019Medical Communications FDA, Obama, Trump, USA, pharma, regulation
The overall number of warning letters being sent out by the FDA has dropped under President Donald Trump, according to …
NICE recommends Pfizer’s Vizimpro, rejects AstraZeneca’s Tagrisso, in non-small cell lung cancer
July 5, 2019Medical Communications, Sales and Marketing Cancer, NHS, NICE, Pfizer, UK, Vizimpro, lung cancer, pharma
NICE has announced its decision to recommend Pfizer’s Vizimpro (Dacomitinib) in the treatment of non-small-cell lung cancer (NSCLC) – a …
Scientists use cold virus to treat bladder cancer
July 5, 2019Medical Communications, Research and Development CVA21, Cancer, bladder cancer, oncology, oncolytic, pharma, virus
A strain of the virus that causes the common cold has been found to potentially target, infect and kill cancer …
FDA approves multiple myeloma therapy Xpovio despite safety concerns
July 4, 2019Sales and Marketing FDA, Karyopharm, Xpovio, multiple myeloma, pharma
The FDA has made the controversial decision to approve the nuclear export inhibitor Xpovio (selinexor) from Karyopharm Therapeutics, in combination …
Cancer cost US more than $94 billion in lost earnings in 2015
July 4, 2019Research and Development Cancer, economics, health, lost earnings, oncology, pharma
Cancer deaths cost the US economy $94.4 billion in lifetime earnings in 2015, according to figures from the American Cancer …
Prices hiked on 3,400 drugs in first half of 2019
July 4, 2019Research and Development, Sales and Marketing abstruse, access, generics, pharma, prescription, pricing
There have been price hikes on more than 3,400 drugs in the United States in the first six months of …
European approval for Alexion’s Ultomiris in rare blood disease
July 4, 2019Sales and Marketing Alexion, Europe, Ultomiris, paroxysmal nocturnal haemoglobinuria
Alexion has received marketing authorisation from the European Commission for its long-acting C5 complement inhibitor Ultomiris (ravulizumab) in the treatment …
UK Government call for more research into medicinal cannabis
July 4, 2019Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CBMP, Marijuana, UK, medicinal cannabis, pharma, politics
The British government has called for more research into cannabis-based medicinal products (CBMPs). In a paper published on 3 July, …
ViiV’s Dovato approved in Europe as treatment option for HIV-1
July 3, 2019Research and Development, Sales and Marketing Dovato, GSK, HIV, ViiV Healthcare, pharma
ViiV Healthcare, the specialist HIV firm majority owned by GSK, is celebrating the news that the European Commission has chosen …
Researchers use gene-editing tool CRISPR to cure mice of HIV
July 3, 2019Research and Development AIDS, HIV, Nature Communications, crispr, mice, pharma
American scientists have been able to combine a new form of antiretroviral therapy (ART) with gene editing tool CRISPR/Cas9 to …
Roche’s Xofluza proves non-inferior to Tamiflu in children with flu
July 3, 2019Research and Development Roche, Tamiflu, flu, pharma
Roche has unveiled new Phase 3 data indicating that Xofluza (baloxavir marboxil) was well-tolerated and of comparable efficacy to its …
US Government awarded new patent on preventative HIV drugs PrEP
July 3, 2019Research and Development, Sales and Marketing Gilead, HHS, government, pharma
The Department of Health and Human Services (HHS) has been awarded a new patent on drugs that prevent HIV. The …
Elizabeth Warren calls on former FDA commissioner Scott Gottlieb to resign from board of Pfizer
July 2, 2019Research and Development FDA, Pfizer, Scott Gottlieb, health, pharma, public health
Democrat Presidential candidate Elizabeth Warren has criticised Scott Gottlieb for joining Pfizer. In a letter to Gottlieb, Senator Warren …
Biogen unveils promising new data for Spinraza in pre-symptomatic infants with spinal muscular atrophy
July 2, 2019Manufacturing and Production, Research and Development Biogen, Spinraza, pharma, spinal muscular atrophy
Biogen has introduced new data on the efficacy of Spinraza in the treatment of pre-symptomatic infants in spinal muscular atrophy …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
